Proportion of participants with resolution or improvement of symptoms up to 30 days · adults with acute sinusitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with any adverse event · adults with acute sinusitis
Cyclamen europaeum probably leads to higher proportion of participants with any adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Time to recovery/time to clinical stability ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Change in the severity status of bronchiolitis Assessed using a variety of scales · infants up to 24 months of age with acute bronchiolitis
Slow passive expiration showed no clear difference in change in the severity status of bronchiolitis Assessed using a… compared with control (low certainty).
1 finding from 1 review
Adverse events ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Time to recovery/time to clinical stability ( · infants up to 24 months of age with acute bronchiolitis
1 finding from 1 review
Change in the severity status of bronchiolitis Assessed using a variety of scales · infants up to 24 months of age with acute bronchiolitis
It is very uncertain whether forced expiration changes change in the severity status of bronchiolitis Assessed using a… compared with control (very low certainty).
1 finding from 1 review
Adverse events ( · infants up to 24 months of age with acute bronchiolitis
Forced expiration leads to higher adverse events ( compared with control (high certainty).
1 finding from 1 review
Death ‐ all participants · children with acute bacterial meningitis
Maintenance fluids showed no clear difference in death ‐ all participants compared with restricted fluids (low certainty).
1 finding from 1 review
Severe neurological sequelae ‐ acute (within the first 4 weeks) · children with acute bacterial meningitis
Maintenance fluids showed no clear difference in severe neurological sequelae ‐ acute (within the first 4 weeks) compared with restricted fluids (low certainty).
1 finding from 1 review
Severe neurological sequelae ‐ chronic (after the first 4 weeks) · children with acute bacterial meningitis
It is very uncertain whether maintenance fluids changes severe neurological sequelae ‐ chronic (after the first 4 weeks) compared with restricted fluids (very low certainty).
1 finding from 1 review